Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Varenicline and Lorcaserin for Smoking Cessation and Weight Gain Prevention

NCT02412631 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02412631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02412631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Varenicline and Lorcaserin for Smoking Cessation and Weight Gain Prevention
Lead sponsor
Mayo Clinic
Phase
Phase 2/3
Overall status
Terminated
Start date
June 15, 2016
Completion date
April 17, 2020
Enrollment
84 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, smoking cessation